Xylem Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy

62

XYL
Xylem

Last Price:

135.15

Seasonality Move:

9.42%

Sell

34

APLS
Apellis Pharmaceuticals

Last Price:

27.90

Seasonality Move:

25.98%

Buy

62

Xylem (XYL) is a Buy

Is Xylem a Buy, Sell or Hold?

The current Xylem [XYL] share price is $137.46. The Score for XYL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
XYL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

34

Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

The current Apellis Pharmaceuticals [APLS] share price is $27.95. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XYL Stock Price Chart

What is Xylem's stock price today?

The Xylem share price today is $137.46
The current trend is moderately bullish and XYL is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

The Apellis Pharmaceuticals share price today is $27.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

XYL Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.99	Buy
Relative Strength Index (14 RSI):	60.37	Buy
Chaikin Money Flow:	151102	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(132.65 - 136.05)	Buy
Bollinger Bands (100):	(131.35 - 138.97)	Buy

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.21	Sell
Relative Strength Index (14 RSI):	34	Sell
Chaikin Money Flow:	-61032	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(26.9 - 34.22)	Sell
Bollinger Bands (100):	(32.37 - 41.13)	Sell

XYL Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	135.87	Buy
20-day SMA:	134.91	Buy
50-day SMA:	133.2	Buy
200-day SMA:	130.63	Buy
8-day EMA:	136.12	Buy
20-day EMA:	134.94	Buy
50-day EMA:	134.23	Buy
200-day EMA:	128.88	Buy

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	27.35	Buy
20-day SMA:	29.1	Sell
50-day SMA:	34.42	Sell
200-day SMA:	47.21	Sell
8-day EMA:	27.73	Buy
20-day EMA:	29.48	Sell
50-day EMA:	33.11	Sell
200-day EMA:	42.85	Sell

Xylem Earnings Growth & XYL Earnings Dates

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.30 per share, and an increase next year of $1.30 per share.

Xylem Technical Analysis

	Oct 3	Oct 4	Oct 7	Oct 8	Oct 9	Oct 10	Oct 11	Oct 14	Oct 15	Oct 16
	Oct
	03	04	07	08	09	10	11	14	15	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

	Oct 3	Oct 4	Oct 7	Oct 8	Oct 9	Oct 10	Oct 11	Oct 14	Oct 15	Oct 16
	Oct
	03	04	07	08	09	10	11	14	15	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):